Barbara Leyman

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ David Pauling as attorney-in-fact for Barbara Leyman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Leyman:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. Chief Business Officer Restricted Stock Units (RSUs) 75,000 $114,920 $1.36 08 Jul 2025 Direct
SUTRO BIOPHARMA, INC. Chief Business Officer Common Stock 16,056 $12,523 $0.7800 08 Jul 2025 Direct
SUTRO BIOPHARMA, INC. Chief Business Officer Stock Option (Right to Buy) 91,000 04 Apr 2025 Direct

Insider Reports Filed by Barbara Leyman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STRO SUTRO BIOPHARMA, INC. 08 Jul 2025 3 -$6,976 4 Chief Business Officer 26 Aug 2025, 21:21
STRO SUTRO BIOPHARMA, INC. 04 Apr 2025 2 $0 4 Chief Business Dev. Officer 08 Apr 2025, 16:09
STRO SUTRO BIOPHARMA, INC. 08 Jul 2024 2 $0 4 Chief Business Dev. Officer 10 Jul 2024, 16:11
STRO SUTRO BIOPHARMA, INC. 08 Jul 2024 0 $0 3 Chief Business Dev. Officer 10 Jul 2024, 16:10